CAMP and breast carcinoma: The results demonstrated that the expression levels of OLR1, ADIPOR1, CEACAM6, DNASE2, CD53, BMF, and CAMP were significantly elevated in breast cancer samples compared to healthy controls (p < 0.05) (Figure 4A–G).